Veeva maintains a premium valuation supported by robust revenue growth and consistent profitability metrics. Analyst price target reductions to $212-$275 still imply significant upside from current levels.

Market sentiment remains mixed with multiple analyst reiterations despite lowered price targets. The stock is emerging as a GARP candidate, balancing growth expectations with current valuation concerns.

The reiteration of overweight ratings suggests underlying confidence in Veeva's long-term strategic positioning. However, consistent price target reductions across major firms indicate near-term headwinds.

Technically, Veeva shows resilience as it holds near the $180 level despite multiple analyst downgrades. The consolidation pattern suggests accumulation ahead of next earnings catalyst.